United States · FDA National Drug Code directory
Medroxyprogesterone Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0555-0873_b8f519a9-a8d0-4dd5-b138-564fb579c461
- Product NDC
- 0555-0873
- Form
- TABLET
- Composition / generic term
- Medroxyprogesterone Acetate
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19961203
- Source listing expiry
- 20261231
Source-listed ingredients
- MEDROXYPROGESTERONE ACETATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (0555-0873-02) · 0555-0873-02
- 500 TABLET in 1 BOTTLE (0555-0873-04) · 0555-0873-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →